Study of Safety and Efficacy of HS-10542 in Patients With Paroxysmal Nocturnal Hemoglobinuria
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Paroxysmal Nocturnal Hemoglobinuria
Related studies linked through entity extraction aliases.
Danicopan PMS in Korea
- Status
- RECRUITING
- Phase
- N/A
A Study of Iptacopan in Korean Patients With Paroxysmal Nocturnal Hemoglobinuria or C3 Glomerulopathy
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Long-term Safety of Danicopan: IPIG Registry-based Cohort Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Assess Long-Term Safety of Danicopan Add-on Therapy in Participants With Paroxysmal Nocturnal Hemoglobinuria: Analysis of IPIG-Registry Data
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Efficacy, Safety, and Pharmacokinetics of LP-005 Injection in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Long-term Efficacy and Safety of NTQ5082 Capsules
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Phase III Study of NTQ5082 Capsules in the Treatment of Paroxysmal Nocturnal Hemoglobinuria Patients
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Study to Evaluate How Pozelimab + Cemdisiran Combination Therapy Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Whose Current Treatment is Not Working Efficiently
- Status
- RECRUITING
- Phase
- PHASE3
NIS PDC the Efficacy and Safety of Iptacopan in Adults in Routine Clinical Practice
- Status
- TERMINATED
- Phase
- N/A
A Clinical Study to Evaluate the Effect of Food on the Pharmacokinetic Profiles of HRS-5965 Capsules in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Study of Safety and Efficacy of MY008211A in Patients With Residual Anemia Despite Anti-C5 Antibody Treatment
- Status
- RECRUITING
- Phase
- PHASE3
A Multi-center, Ambispective Cohort Study to Evaluate the Impact of Iptacopan for Adult Patients With PNH in China
- Status
- RECRUITING
- Phase
- N/A
A Study of NTQ5082 Capsules in the Treatment of Paroxysmal Nocturnal Hemoglobinuria Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Long-term Safety and Tolerability of HSK39297 in Patients With Paroxysmal Nocturnal Hemoglobinuria
- Status
- RECRUITING
- Phase
- PHASE2
Efficacy and Safety of HRS-5965 in Patients With PNH Who Are Still Anemia After Anti-C5 Antibody Treatment
- Status
- COMPLETED
- Phase
- PHASE3
Specified Drug-use Surveillance of Fabhalta Capsules
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Study to Evaluate the Efficacy and Safety of Oral HRS-5965 in Adult Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Who Are Naive to Complement Inhibitor Therapy
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Ravulizumab in Chinese Adults Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Status
- COMPLETED
- Phase
- PHASE3
To Evaluate the Effect of Single Oral Dose of MY008211A Tablets on QTc Interval in Healthy Subjects
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1